Sheep Pox Vaccine (RM-65)
Veterinary biological for livestock disease prevention.
Products & capabilities
From our flagship PCV-13 vaccine to comprehensive development and manufacturing capabilities across every major dosage form, Apex Evergreen makes medicine across the full spectrum of human and veterinary health — and shapes new products around partner needs.
We are only the second company in the world — after Pfizer — to achieve access to the PCV-13 vaccine at scale. Protecting against 13 serotypes of Streptococcus pneumoniae, PCV-13 guards against pneumonia, meningitis, and septicaemia — diseases that claim over 1.6 million lives annually. For markets across Latin America, Sub-Saharan Africa, and Southeast Asia, our access to WHO-certified PCV-13 is not a business achievement.
It is a lifesaving imperative.
Veterinary biological for livestock disease prevention.
What we can make
Across 21 facilities, Apex Evergreen has the capability to develop and manufacture an exceptional range of dosage forms and formats — and to create new products tailored to partner and market requirements.
Therapy areas
Our broad portfolio spans development and manufacturing capability across therapy areas including:
Packaging
Flexible packaging formats to suit every market and product:
Partner with us
Apex Evergreen develops and manufactures to partner requirements. Whether you're seeking an existing product, a new formulation, a specific dosage form, or a development partner for your market — tell us what you need, and let's start the conversation.
The right products
From flagship vaccines to made-to-order formulations, we help partners match the right product to the patients they serve.